Thermo Fisher Scientific is trading at $693.54, up 3.02% in pre-market on October 15, 2026, amid defensive buying across healthcare; no clear company-specific announcement explains the move. - Hotter U.S. inflation revived rate concerns and pressured technology stocks as investors favored sectors viewed as more resilient. - The sector context does not establish a company-specific catalyst. The next scheduled earnings report is October 21; the dividend payable October 15 was announced in July.